Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
HUMORAL ANTIBODIES AND RESISTANCE OF VACCINATED AND CONVALESCENT MONKEYS TO POLIOMYELITIS VIRUS.
The Journal of experimental medicine·2009
ON THE PRESENCE IN ANTIPNEUMOCOCCUS SERUM OF TYPE-SPECIFIC PROTECTIVE ANTIBODY NOT NEUTRALIZED BY HOMOLOGOUS SPECIFIC SOLUBLE SUBSTANCE.
The Journal of experimental medicine·2009
AN ACQUIRED RESISTANCE OF GROWING ANIMALS TO CERTAIN NEUROTROPIC VIRUSES IN THE ABSENCE OF HUMORAL ANTIBODIES OR PREVIOUS EXPOSURE TO INFECTION.
The Journal of experimental medicine·2009
INFLUENCE OF HOST FACTORS ON NEUROINVASIVENESS OF VESICULAR STOMATITIS VIRUS : IV. VARIATIONS IN NEUROINVASIVENESS IN DIFIERENT SPECIES.
The Journal of experimental medicine·2009
THE NATURAL HISTORY OF HUMAN POLIOMYELITIS : II. ELIMINATION OF THE VIRUS.
The Journal of experimental medicine·2009
THE NATURAL HISTORY OF HUMAN POLIOMYELITIS : I. DISTRIBUTION OF VIRUS IN NERVOUS AND NON-NERVOUS TISSUES.
The Journal of experimental medicine·2009
International challenges and public policy issues.
Developments in biological standardization·2000
Standardisation and licensing of combination vaccines based on DTP.
Developments in biological standardization·2000
The transmissible spongiform encephalopathy agents: concerns and responses of United States regulatory agencies in maintaining the safety of biologics.
Developments in biological standardization·2000
Cytokine and growth factor standardization: the need for research to answer modern issues.
Developments in biological standardization·2000
Alternatives to the use of animals for bacterial toxins and antitoxins.
Developments in biological standardization·2000
Cell substrates: lessons learned and challenges remaining.
Developments in biological standardization·2000
Tumor context determines ARID1A effects on gastric cancer immunity.
bioRxiv : the preprint server for biology·2026